Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1.

Abstract:

:We tested the cytotoxic action of 8-hydroxyguanine (8ohG) by observing the viability of several leukemic cell lines (KG-1, U937, Jurkat and K 562) in the presence of 8-hydroxydeoxyguanosine (8ohdG), a nucleoside of 8ohG. It was found that 8ohdG showed cytotoxic action only to KG-1 and that only KG-1 showed a homozygous arginine 209 to glutamine mutation in the hOGG1 gene with an almost negligible hOGG1 enzyme activity. Possibly, the selective cytotoxicity in 8ohdG to KG-1 may be due to its low capacity to cope with an increase in the 8ohG level in DNA resulting from the incorporation of 8ohdG present in the culture media. The mutational impairment of hOGG1 in KG-1 is the first report in leukemic cell lines. Using KG-1 with impaired hOGG1, we demonstrated cytotoxicity of 8ohdG probably due to its incorporation into cellular DNA. This new property of KG-1 may allow it to serve as an useful tool for studies of OGG1, oxidative DNA damage and the cytotoxic action of 8ohG. Oncogene (2000) 19, 4476 - 4479.

journal_name

Oncogene

journal_title

Oncogene

authors

Hyun JW,Choi JY,Zeng HH,Lee YS,Kim HS,Yoon SH,Chung MH

doi

10.1038/sj.onc.1203787

subject

Has Abstract

pub_date

2000-09-14 00:00:00

pages

4476-9

issue

39

eissn

0950-9232

issn

1476-5594

journal_volume

19

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • A delayed chemically induced tumorigenesis in Brca2 mutant mice.

    abstract::BRCA2 is a breast cancer susceptibility gene. Germline mutations of BRCA2 account for about 10-30% of familial breast cancer cases. Consistent with its tumor-suppressor activity, BRCA2 plays an important role in DNA repair. To assess the susceptibility of carriers of mutant BRCA2 to tumorigenesis induced by DNA-damagi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207314

    authors: Yan DH,Wen Y,Su LK,Xia W,Wang SC,Zhang S,Gan L,Lee DF,Spohn B,Frey JA,Hortobagyi GN,Hung MC

    更新日期:2004-03-11 00:00:00

  • Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.

    abstract::Signal transducers and activators of transcription (Stats) are known to transduce signals from the cell surface to the nucleus in cytokine receptor signaling. We examined the capacity of platelet-derived growth factor (PDGF) receptor to interact with and activate Stat molecules. Activation of the PDGF beta-receptor le...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201555

    authors: Valgeirsdóttir S,Paukku K,Silvennoinen O,Heldin CH,Claesson-Welsh L

    更新日期:1998-01-29 00:00:00

  • BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.

    abstract::High-grade gliomas (HGG) afflict both children and adults and respond poorly to current therapies. Epigenetic regulators have a role in gliomagenesis, but a broad, functional investigation of the impact and role of specific epigenetic targets has not been undertaken. Using a two-step, in vitro/in vivo epigenomic shRNA...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1125-7

    authors: Green AL,DeSisto J,Flannery P,Lemma R,Knox A,Lemieux M,Sanford B,O'Rourke R,Ramkissoon S,Jones K,Perry J,Hui X,Moroze E,Balakrishnan I,O'Neill AF,Dunn K,DeRyckere D,Danis E,Safadi A,Gilani A,Hubbell-Engler B,Nus

    更新日期:2020-03-01 00:00:00

  • Identifying targets for the restoration and reactivation of BRM.

    abstract::Brahma (BRM) is a novel anticancer gene, which is frequently inactivated in a variety of tumor types. Unlike many anticancer genes, BRM is not mutated, but rather epigenetically silenced. In addition, histone deacetylase complex (HDAC) inhibitors are known to reverse BRM silencing, but they also inactivate it via acet...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.613

    authors: Kahali B,Gramling SJ,Marquez SB,Thompson K,Lu L,Reisman D

    更新日期:2014-01-30 00:00:00

  • SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.

    abstract::Liver metastasis remains a serious problem in the management of gastric cancer (GC). Our aims were to identify through transcriptome analysis a molecule that mediates hepatic metastasis in GC, and to evaluate its potential as a diagnostic marker and a therapeutic target. The effects of knocking out a relevant molecule...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0335-8

    authors: Kanda M,Tanaka H,Shimizu D,Miwa T,Umeda S,Tanaka C,Kobayashi D,Hattori N,Suenaga M,Hayashi M,Iwata N,Yamada S,Fujiwara M,Kodera Y

    更新日期:2018-09-01 00:00:00

  • Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.

    abstract::While studying Bim, a BH3-only proapoptotic protein, we identified an approximately 36 kDa protein, which was abundantly expressed in all five strains of primary normal human prostate (NHP) epithelial cells but significantly reduced or lost in seven prostate cancer cell lines. The approximately 36 kDa protein was subs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206196

    authors: Liu JW,Shen JJ,Tanzillo-Swarts A,Bhatia B,Maldonado CM,Person MD,Lau SS,Tang DG

    更新日期:2003-03-13 00:00:00

  • Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

    abstract::Advanced Bladder Cancer (BLCA) remains a clinical challenge that lacks effective therapeutic measures. Here, we show that distinct, stage-wise metabolic alterations in BLCA are associated with the loss of function of aldehyde oxidase (AOX1). AOX1 associated metabolites have a high predictive value for advanced BLCA an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0902-7

    authors: Vantaku V,Putluri V,Bader DA,Maity S,Ma J,Arnold JM,Rajapakshe K,Donepudi SR,von Rundstedt FC,Devarakonda V,Dubrulle J,Karanam B,McGuire SE,Stossi F,Jain AK,Coarfa C,Cao Q,Sikora AG,Villanueva H,Kavuri SM,Lotan Y

    更新日期:2020-10-01 00:00:00

  • Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma.

    abstract::Chromosomal region 8p11.2-p12 is consistently amplified in human breast cancer. We have constructed a 2.8 Mb YAC contig of this region, centered on the human Fibroblast Growth Factor Receptor 1 (FGFR1) locus and encompassing the Adrenergic beta 3 Receptor (ADRB3) locus. A smaller centromeric YAC contig spanning 1.4 Mb...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Dib A,Adélaïde J,Chaffanet M,Imbert A,Le Paslier D,Jacquemier J,Gaudray P,Theillet C,Birnbaum D,Pébusque MJ

    更新日期:1995-03-02 00:00:00

  • Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines.

    abstract::Ectopic expression of the intracellular domain of NOTCH-4/INT-3 leads to tumorigenesis in the mouse mammary gland. This results from a gain-of-function mutation. To evaluate gain-of-function NOTCH-4/INT-3 activity in human cancers we have surveyed human breast, lung, and colon carcinoma tissue culture cell lines for e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203295

    authors: Imatani A,Callahan R

    更新日期:2000-01-13 00:00:00

  • Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.

    abstract::To investigate the mechanisms of colorectal carcinogenesis, we searched for genes regulated by adenomatous polyposis coli gene product (APC) and identified a novel gene, termed HELAD1 (helicase, APC down-regulated 1). A recombinant polypeptide representing the ATPases associated with cellular activities (AAA) domain o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205751

    authors: Ishiguro H,Shimokawa T,Tsunoda T,Tanaka T,Fujii Y,Nakamura Y,Furukawa Y

    更新日期:2002-09-12 00:00:00

  • The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.

    abstract::As a result of the synovial sarcoma-associated t(X;18) translocation, the SS18 gene on chromosome 18 is fused to either one of the three closely related SSX genes on the X chromosome. The SS18 protein is thought to act as a transcriptional co-activator, whereas the SSX proteins are thought to act as transcriptional co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210688

    authors: de Bruijn DR,van Dijk AH,Willemse MP,van Kessel AG

    更新日期:2008-01-24 00:00:00

  • STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation.

    abstract::Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the synthesis of prostaglandins, promotes the development of colorectal cancer, and is a key molecular target of non-steroidal anti-inflammatory drugs, compounds that reduce the relative risk of developing colon cancer. In this study, we showed that interferon gamm...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210015

    authors: Klampfer L,Huang J,Kaler P,Sasazuki T,Shirasawa S,Augenlicht L

    更新日期:2007-03-29 00:00:00

  • hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.

    abstract::In the presence of ERbeta, trans-hydroxytamoxifen (TOT) protects cells against 17beta-estradiol (E(2))-induced oxidative DNA damage (ODD) and this correlates with increased expression of the antioxidative enzyme quinone reductase (QR). Here, we investigate the molecular mechanism responsible for ERbeta-mediated protec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.235

    authors: Sripathy SP,Chaplin LJ,Gaikwad NW,Rogan EG,Montano MM

    更新日期:2008-10-23 00:00:00

  • hAda3 regulates p14ARF-induced p53 acetylation and senescence.

    abstract::Acetylation is thought to be a key event for p53 activation. We demonstrate that p14ARF-induced senescence of human mammary epithelial cells (MEC) is associated with p53 acetylation and requires hAda3, a component of histone acetyltransferase complexes and a p53 transcriptional coactivator. Expression of the N-termina...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210462

    authors: Sekaric P,Shamanin VA,Luo J,Androphy EJ

    更新日期:2007-09-20 00:00:00

  • Adenovirus E4orf4 protein interacts with both Balpha and B' subunits of protein phosphatase 2A, but E4orf4-induced apoptosis is mediated only by the interaction with Balpha.

    abstract::Adenovirus E4orf4 protein is a multifunctional viral regulator, which is involved in down regulation of virally-modulated signal transduction, in control of alternative splicing of viral mRNAs, and in induction of apoptosis in transformed cells. It has been previously shown that E4orf4 interacts with protein phosphata...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203705

    authors: Shtrichman R,Sharf R,Kleinberger T

    更新日期:2000-08-03 00:00:00

  • Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

    abstract::Abundant data support a key role for the transcription factor nuclear factor-kappaB (NF-kappaB) signaling pathway in controlling the initiation and progression of human cancer. NF-kappaB and associated regulatory proteins such as IkappaB kinase (IKK) are activated downstream of many oncoproteins and there is much evid...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209942

    authors: Bassères DS,Baldwin AS

    更新日期:2006-10-30 00:00:00

  • Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.

    abstract::To understand the function of the individual oncogenes of HPV16 in modulating the cellular response to apoptogenic signals, we used human keratinocytes immortalized with either E6, E7 or E6/E7 oncoproteins as model system. Applying CD95 antibodies or recombinant CD95 ligand, only the E7-immortalized cells underwent ex...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204979

    authors: Aguilar-Lemarroy A,Gariglio P,Whitaker NJ,Eichhorst ST,zur Hausen H,Krammer PH,Rösl F

    更新日期:2002-01-10 00:00:00

  • The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death.

    abstract::The maintenance of genome stability is essential for the cell as the integrity of genomic information guaranties reproduction of a whole organism. DNA damage occurring in response to different natural and nonnatural stimuli (errors in DNA replication, UV radiation, chemical agents, etc.) is normally detected by specia...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0980-6

    authors: Prokhorova EA,Egorshina AY,Zhivotovsky B,Kopeina GS

    更新日期:2020-01-01 00:00:00

  • The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis.

    abstract::Expression of viral proteins may result in susceptibility of cells to the cytotoxic effect of Tumor Necrosis Factor Alpha (TNF). While murine C127 cells containing the bovine papillomavirus type 1 (BPV-1) genome were reported to exhibit increased TNF sensitivity, the gene(s) responsible was not identified. The BPV-1 E...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202373

    authors: Rapp L,Liu Y,Hong Y,Androphy EJ,Chen JJ

    更新日期:1999-01-21 00:00:00

  • PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity.

    abstract::The transcription factor PU.1 is essential for terminal myeloid differentiation, B- and T-cell development, erythropoiesis and hematopoietic stem cell maintenance. PU.1 functions as oncogene in Friend virus-induced erythroleukemia and as tumor suppressor in acute myeloid leukemias. Moreover, Friend virus-induced eryth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211004

    authors: Tschan MP,Reddy VA,Ress A,Arvidsson G,Fey MF,Torbett BE

    更新日期:2008-05-29 00:00:00

  • GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.

    abstract::GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a novel tumor suppressor regulated by interferon/retinoid combination. We have recently shown that GRIM-19 inhibits v-Src-induced oncogenic transformation and metastatic behavior of cells. Oncogenic v-Src induces cell motility by cytoskeletal r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.480

    authors: Sun P,Nallar SC,Kalakonda S,Lindner DJ,Martin SS,Kalvakolanu DV

    更新日期:2009-03-12 00:00:00

  • F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.

    abstract::Cellular adhesion to extracellular matrix is a central phenomenon for the maintenance of tissue integrity and cellular movement. Collectively, these processes are regulated by a fine-tuned balance between the formation and loosening of adhesive contacts, a process involving integrins, and the elevation and diminution ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210883

    authors: Sales KJ,Boddy SC,Jabbour HN

    更新日期:2008-04-10 00:00:00

  • Regulation of Laloo by the Xenopus C-terminal Src kinase (Xcsk) during early vertebrate development.

    abstract::Mesoderm formation in the frog, Xenopus laevis, is dependent on the activity of one or more members of the Src family kinases; the molecular interactions underlying this requirement are not well understood. The C-terminal Src Kinase (Csk) is a potent inhibitor of Src activity, and is required for normal mammalian deve...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204672

    authors: Song Y,Cohler AN,Weinstein DC

    更新日期:2001-08-23 00:00:00

  • Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.

    abstract::MEK kinases (MEKKs) are serine-threonine kinases that regulate sequential protein phosphorylation pathways involving mitogen-activated protein kinases (MAPKs), including members of the Jun kinase (JNK) family. MEKK1 is a 196 kDa protein that when cleaved by caspase-3-like proteases generates an active COOH-terminal ki...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201421

    authors: Widmann C,Johnson NL,Gardner AM,Smith RJ,Johnson GL

    更新日期:1997-11-13 00:00:00

  • Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.

    abstract::Colitis-associated colorectal cancers are an etiologically distinct subgroup of colon cancers that occur in individuals suffering from inflammatory bowel disease and arise as a consequence of persistent exposure of hyperproliferative epithelial stem cells to an inflammatory microenvironment. An intrinsic defect in the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.545

    authors: Kosa P,Szabo R,Molinolo AA,Bugge TH

    更新日期:2012-08-09 00:00:00

  • Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines.

    abstract::Overexpression of the nuclear phosphoprotein p53 has been detected in many different transformed human cell lines and primary adult tumors. Elevated steady-state levels of p53 appear to be the result of an increase in the stability of the protein and, in adult cancers, high levels of the protein are associated with mu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Davidoff AM,Pence JC,Shorter NA,Iglehart JD,Marks JR

    更新日期:1992-01-01 00:00:00

  • Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway.

    abstract::Hypoxic microenvironment supports cancer stem cell survival, causes poor response to anticancer therapy and tumor recurrence. Inhibition of Notch-1 signaling in adenocarcinoma of the lung (ACL) cells causes apoptosis specifically under hypoxia. Here, we found that Akt-1 activation is a key mediator of Notch-1 pro-surv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.7

    authors: Eliasz S,Liang S,Chen Y,De Marco MA,Machek O,Skucha S,Miele L,Bocchetta M

    更新日期:2010-04-29 00:00:00

  • Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.

    abstract::The c-erbB-2 proto-oncogene encodes a receptor tyrosine kinase (RTK) closely related to the epidermal growth factor receptor (EGFR). Overexpression of erbB-2 occurs in approximately 20% of human breast tumours, where increased expression correlates with poor patient prognosis. The EGFR is coupled to the Ras signalling...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Janes PW,Daly RJ,deFazio A,Sutherland RL

    更新日期:1994-12-01 00:00:00

  • Oncology studies using siRNA libraries: the dawn of RNAi-based genomics.

    abstract::High-throughput, human cell-based applications of RNA-mediated interference (RNAi) have emerged in recent years as perhaps the most powerful of a 'second wave' of functional genomics technologies. The available reagents and methodologies for RNAi screening studies now enable a wide range of different scopes and scales...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208072

    authors: Sachse C,Echeverri CJ

    更新日期:2004-11-01 00:00:00

  • The cyclin-dependent kinase inhibitor p27Kip1 is localized to the cytosol in Swiss/3T3 cells.

    abstract::p27Kip1 plays an important role in cell cycle progression by negatively regulating the activity of cyclin-Cdk complexes. To understand how p27Kip1 functions, the level and subcellular location of p27Kip1 in Swiss/3T3 cells following serum stimulation of quiescent cells was examined. Surprisingly, p27Kip1 was observed ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202912

    authors: Wang G,Miskimins R,Miskimins WK

    更新日期:1999-09-16 00:00:00